Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-020-00458-y http://scihub22266oqcxt.onion/10.1038/s41577-020-00458-y 33024283!7537977!33024283     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Immunol 2020 ; 20 (11): 645-646 Nephropedia Template TP {{tp|p=33024283|t=2020. Do cross-reactive antibodies cause neuropathology in COVID-19?|pdf=|usr=}}{{33024283}} gab.com Text Do cross-reactive antibodies cause neuropathology in COVID-19 JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33024283 #FOAvip Neurological symptoms are seen in patients with COVID-19 and can persist or re-emerge after clearance of SARS-CoV-2. Recent findings suggest that antibodies to SARS-CoV-2 can cross-react with mammalian proteins. Focusing on neurological symptoms, we discuss whether these cross-reactive antibodies could contribute to COVID-19 disease pathology and to the persistence of symptoms in patients who have cleared the initial viral infection. Twit Text FOAVip Do cross-reactive antibodies cause neuropathology in COVID-19 ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33024283 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33024283 #FOAvip English Wikipedia <ref>{{Cite pmid|33024283}}</ref> Do cross-reactive antibodies cause neuropathology in COVID-19? #MMPMID33024283 Kreye J; Reincke SM; Pruss H Nat Rev Immunol 2020[Nov]; 20 (11): 645-646 PMID33024283show ga Neurological symptoms are seen in patients with COVID-19 and can persist or re-emerge after clearance of SARS-CoV-2. Recent findings suggest that antibodies to SARS-CoV-2 can cross-react with mammalian proteins. Focusing on neurological symptoms, we discuss whether these cross-reactive antibodies could contribute to COVID-19 disease pathology and to the persistence of symptoms in patients who have cleared the initial viral infection. |Antibodies, Monoclonal/biosynthesis[MESH] |Antibodies, Neutralizing/biosynthesis[MESH] |Antibodies, Viral/*biosynthesis[MESH] |Autoimmunity[MESH] |Betacoronavirus/immunology/pathogenicity[MESH] |Brain Diseases/complications/diagnosis/*immunology[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/diagnosis/*immunology[MESH] |Cross Reactions[MESH] |Headache/complications/diagnosis/immunology[MESH] |Humans[MESH] |Pandemics[MESH] |Parkinsonian Disorders/complications/diagnosis/*immunology[MESH] |Pneumonia, Viral/complications/diagnosis/*immunology[MESH] |SARS-CoV-2[MESH] |Seizures/complications/diagnosis/*immunology[MESH]Do cross-reactive antibodies cause neuropathology in COVID-19?(epmc).pdf DeepDyve Pubget Overpricing